{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T18:48:15Z","timestamp":1757702895349,"version":"3.37.3"},"reference-count":45,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2004,12]]},"DOI":"10.1124\/jpet.104.072843","type":"journal-article","created":{"date-parts":[[2004,11,19]],"date-time":"2004-11-19T02:03:24Z","timestamp":1100829804000},"page":"1264-1271","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Nitric Oxide (NO)-Releasing Naproxen (HCT-3012 [(S)-6-Methoxy-\u03b1-methyl-2-naphthaleneacetic Acid 4-(Nitrooxy)butyl Ester]) Interactions with Aspirin in Gastric Mucosa of Arthritic Rats Reveal a Role for Aspirin-Triggered Lipoxin, Prostaglandins, and NO in Gastric Protection"],"prefix":"10.1016","volume":"311","author":[{"given":"Stefano","family":"Fiorucci","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annarita","family":"Di Lorenzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Renga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvana","family":"Farneti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Morelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Cirino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.104.072843_bib1","doi-asserted-by":"crossref","unstructured":"Bombardier C, Laine L, Reicin A, Shapiro D, Burgos-Vargas R, Davis B, Day R, Ferraz MD, Hawkey CL, Hochberg MC, et al. (2000) Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. N Engl J Med 343:1520\u2013 1528.","DOI":"10.1056\/NEJM200011233432103"},{"key":"10.1124\/jpet.104.072843_bib2","doi-asserted-by":"crossref","unstructured":"Chiang N, Takano T, Clish CB, Petasis NA, Tai H-H, and Serhan CN (1998) Aspirin-triggered 15-epi-lipoxin A4 (ATL) generation by human leukocytes and murine peritonitis exudates: development of a specific 15-epi-LXA4 ELISA. J Pharmacol Exp Ther 287:779\u2013 790.","DOI":"10.1016\/S0022-3565(24)37857-7"},{"key":"10.1124\/jpet.104.072843_bib3","doi-asserted-by":"crossref","unstructured":"Cicala C, Ianaro A, Fiorucci S, Calignano A, Bucci M, Gerli R, Santucci L, Wallace JL, and Cirino G (2000) NO-naproxen modulates inflammation, nociception and downregulates T cell response in rat Freund\u2019s adjuvant arthritis. Br J Pharmacol 130:1399\u2013 1405.","DOI":"10.1038\/sj.bjp.0703449"},{"key":"10.1124\/jpet.104.072843_bib4","doi-asserted-by":"crossref","unstructured":"Cirino G (2003) Nitric oxide releasing drugs: from bench to bedside Dig Liver Dis 35 (Suppl 2):S2\u2013 S8.","DOI":"10.1016\/S1590-8658(03)00046-X"},{"key":"10.1124\/jpet.104.072843_bib5","doi-asserted-by":"crossref","unstructured":"Claria J and Serhan CN (1995) Aspirin triggers previously unrecognized bioactive eicosanoids by human endothelial cell-leukocyte interactions. Proc Natl Acad Sci USA 92:9475\u2013 9479.","DOI":"10.1073\/pnas.92.21.9475"},{"key":"10.1124\/jpet.104.072843_bib6","doi-asserted-by":"crossref","unstructured":"Cleland JG (2002) No reduction in cardiovascular risk with NSAIDs-including aspirin? Lancet 359:92\u2013 93.","DOI":"10.1016\/S0140-6736(02)07332-4"},{"key":"10.1124\/jpet.104.072843_bib7","doi-asserted-by":"crossref","unstructured":"Clish CB, O\u2019Brien JA, Gronert K, Stahl GL, Petasis NA, and Serhan CN (1999) Local and systemic delivery of a stable aspirin-triggered lipoxin prevents neutrophil recruitment in vivo. Proc Natl Acad Sci USA 96:8247\u2013 8252.","DOI":"10.1073\/pnas.96.14.8247"},{"key":"10.1124\/jpet.104.072843_bib8","doi-asserted-by":"crossref","unstructured":"Davies NM, Sharkey KA, Asfaha S, MacNaughton WK, and Wallace JL (1997) Aspirin induced a rapid up-regulation of cyclooxygenase-2 expression in the rat stomach. Aliment Pharmacol Ther 11:1101\u2013 1108.","DOI":"10.1046\/j.1365-2036.1997.00247.x"},{"key":"10.1124\/jpet.104.072843_bib9","doi-asserted-by":"crossref","unstructured":"De Caterina R, Libby P, Peng H-B, Thannickal VJ, Rajavashisth TB, Gimbrone MA Jr, Shin WS, and Liao JK (1995) Nitric oxide decreases cytokine-induced endothelial activation. J Clin Investig 96:60\u2013 68.","DOI":"10.1172\/JCI118074"},{"key":"10.1124\/jpet.104.072843_bib10","doi-asserted-by":"crossref","unstructured":"Filep JG, Zouki C, Petasis NA, Hachicha M, and Serhan CN (1999) Anti-inflammatory actions of lipoxin A(4) stable analogs are demonstrable in human whole blood: modulation of leukocyte adhesion molecules and inhibition of neutrophil-endothelial interactions. Blood 94:4132\u2013 4142.","DOI":"10.1182\/blood.V94.12.4132"},{"key":"10.1124\/jpet.104.072843_bib11","doi-asserted-by":"crossref","unstructured":"Fiore S and Serhan CN (1995) Lipoxin A4 receptor activation is distinct from that of the formyl peptide receptor in myeloid cells: inhibition of CD11\/18 expression by lipoxin A4-lipoxin A4 receptor interaction. Biochemistry 34:16678\u2013 16686.","DOI":"10.1021\/bi00051a016"},{"key":"10.1124\/jpet.104.072843_bib12","doi-asserted-by":"crossref","unstructured":"Fiorucci S, Antonelli E, Burgaud JL, and Morelli A (2001) Nitric oxide-releasing NSAIDs: a review of their current status. Drug Safety 24:801\u2013 811.","DOI":"10.2165\/00002018-200124110-00002"},{"key":"10.1124\/jpet.104.072843_bib13","doi-asserted-by":"crossref","unstructured":"Fiorucci S, Antonelli E, Santucci L, Morelli O, Miglietti M, Federici B, Mannucci R, Del Soldato P, and Morelli A (1999) Gastrointestinal safety of nitric oxide derived aspirin is related to inhibition of ICE-like cysteine protease in rats. Gastroenterology 116:1089\u2013 1106.","DOI":"10.1016\/S0016-5085(99)70012-0"},{"key":"10.1124\/jpet.104.072843_bib14","doi-asserted-by":"crossref","unstructured":"Fiorucci S, Distrutti E, Mencarelli A, Morelli A, Laufor SA, Cirino G, and Wallace JL (2003a) Evidence that 5-lipoxygenase and acetylated cyclooxygenase 2-derived eicosanoids regulate leukocyte-endothelial adherence in response to aspirin. Br J Pharmacol 139:1351\u2013 1359.","DOI":"10.1038\/sj.bjp.0705356"},{"key":"10.1124\/jpet.104.072843_bib15","doi-asserted-by":"crossref","unstructured":"Fiorucci S, Mendes De Lima O, Mencarelli A, Palazzetti B, Distrutti E, Mcknight W, Dicay M, Ma L, Romano M, Morelli A, et al. (2002) COX-2 derived lipoxin A4 increases gastric resistance to aspirin-induced damage. Gastroenterology 123:1598\u2013 1606.","DOI":"10.1053\/gast.2002.36558"},{"key":"10.1124\/jpet.104.072843_bib16","doi-asserted-by":"crossref","unstructured":"Fiorucci S, Santucci L, Wallace JL, Sardina M, Romano M, del Soldato P, and Morelli A (2003b) Interaction of a selective cyclooxygenase-2 inhibitor with aspirin and NO-releasing aspirin in the human gastric mucosa. Proc Natl Acad Sci USA 100:10937\u2013 10941.","DOI":"10.1073\/pnas.1933204100"},{"key":"10.1124\/jpet.104.072843_bib17","doi-asserted-by":"crossref","unstructured":"FitzGerald GA (2003) COX-2 and beyond: approaches to prostaglandin inhibition in human disease. Nat Rev Drug Discov 2:879\u2013 890.","DOI":"10.1038\/nrd1225"},{"key":"10.1124\/jpet.104.072843_bib18","doi-asserted-by":"crossref","unstructured":"Funk CD (2001) Prostaglandins and leukotrienes: advances in eicosanoid biology. Science (Wash DC) 294:1871\u2013 1875.","DOI":"10.1126\/science.294.5548.1871"},{"key":"10.1124\/jpet.104.072843_bib19","doi-asserted-by":"crossref","unstructured":"Hawkey CJ, Jones JI, Atherton CT, Skelly MM, Bebb JR, Fagerholm U, Jonzon B, Karlsson P, and Bjarnason IT (2003) Gastrointestinal safety of AZD3582, a cyclooxygenase inhibiting nitric oxide donator: proof of concept study in humans. Gut 52:1537\u2013 1542.","DOI":"10.1136\/gut.52.11.1537"},{"key":"10.1124\/jpet.104.072843_bib20","doi-asserted-by":"crossref","unstructured":"Jozsef L, Zouki C, Petasis NA, Serhan CN, and Filep JG (2002) Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 inhibit peroxynitrite formation, NF-kappa B and AP-1 activation and IL-8 gene expression in human leukocytes. Proc Natl Acad Sci USA 99:13266\u2013 13271.","DOI":"10.1073\/pnas.202296999"},{"key":"10.1124\/jpet.104.072843_bib21","doi-asserted-by":"crossref","unstructured":"Kato S, Ogawa Y, Tanaka A, Kunikata T, and Takeuchi K (2001) Delayed healing of gastric ulcers in adjuvant arthritis rats: role of acid secretion and basic fibroblast growth factor. Digestion 63:171\u2013 179.","DOI":"10.1159\/000051886"},{"key":"10.1124\/jpet.104.072843_bib22","doi-asserted-by":"crossref","unstructured":"Kato S, Tanaka A, Kunikata T, Nishijima M, and Takeuchi K (1999) Change in gastric mucosal ulcerogenic responses in rats with adjuvant arthritis: role of nitric oxide. Aliment Pharmacol Ther 13:833\u2013 840.","DOI":"10.1046\/j.1365-2036.1999.00548.x"},{"key":"10.1124\/jpet.104.072843_bib23","doi-asserted-by":"crossref","unstructured":"Khan BV, Harrison DG, Olbrych MT, Alexander RW, and Medford RM (1996) Nitric oxide regulates vascular cell adhesion molecule-1 gene expression and redox-sensitive transcriptional events in human vascular endothelial cells. Proc Natl Acad Sci USA 93:9114\u2013 9119.","DOI":"10.1073\/pnas.93.17.9114"},{"key":"10.1124\/jpet.104.072843_bib24","doi-asserted-by":"crossref","unstructured":"Lecomte M, Laneuville O, Ji C, Dewitt DL, and Smith WL (1994) Acetylation of human prostaglandin endoperoxide synthase-2 (cyclooxygenase-2) by aspirin. J Biol Chem 269:13207\u2013 13215.","DOI":"10.1016\/S0021-9258(17)36820-5"},{"key":"10.1124\/jpet.104.072843_bib25","doi-asserted-by":"crossref","unstructured":"Loll PJ, Picot D, and Garavito RM (1995) The structural basis of aspirin activity inferred from the crystal structure of inactivated prostaglandin H2 synthase. Nat Struct Biol 2:637\u2013 643.","DOI":"10.1038\/nsb0895-637"},{"key":"10.1124\/jpet.104.072843_bib26","doi-asserted-by":"crossref","unstructured":"Lopez-Belmonte J, Whittle BJ, and Moncada S (1993) The actions of nitric oxide donors in the prevention or induction of injury to the rat gastric mucosa. Br J Pharmacol 108:73\u2013 78.","DOI":"10.1111\/j.1476-5381.1993.tb13442.x"},{"key":"10.1124\/jpet.104.072843_bib27","doi-asserted-by":"crossref","unstructured":"Mancini JA, Vickers PJ, O\u2019Neill GP, Boil C, Falgueyret JP, and Riendeau D (1997) Altered sensitivity of aspirin-acetylated prostaglandin G\/H synthase-2 to inhibition by nonsteroidal anti-inflammatory drugs. Mol Pharmacol 51:52\u2013 60.","DOI":"10.1124\/mol.51.1.52"},{"key":"10.1124\/jpet.104.072843_bib28","doi-asserted-by":"crossref","unstructured":"McCafferty DM, Granger DN, and Wallace JL (1995) Indometacin-induced gastric injury and leukocyte adherence in arthritic versus healthy rats. Gastroenterology 109:1173\u2013 1180.","DOI":"10.1016\/0016-5085(95)90576-6"},{"key":"10.1124\/jpet.104.072843_bib29","doi-asserted-by":"crossref","unstructured":"Muscar\u00e0 MN, McKnight W, Del Soldato P, and Wallace JL (1998) Effect of a nitric oxide-releasing naproxen derivate on hypertension and gastric damage induced chronic nitric oxide inhibition in the rat. Life Sci 62:PL235\u2013 PL241.","DOI":"10.1016\/S0024-3205(98)00072-1"},{"key":"10.1124\/jpet.104.072843_bib30","doi-asserted-by":"crossref","unstructured":"Muscar\u00e0 MN, McKnight W, Lovren F, Triggle CR, Cirino G, and Wallace JL (2000) Antihypertensive properties of a nitric oxide-releasing naproxen derivative in two-kidney, one-clip rats. Am J Phisiol Heart Circ Physiol 279:H528\u2013 H535.","DOI":"10.1152\/ajpheart.2000.279.2.H528"},{"key":"10.1124\/jpet.104.072843_bib31","doi-asserted-by":"crossref","unstructured":"Patrono C (1994) Aspirin as an antiplatelet drug. N Engl J Med 330:1287\u2013 1294.","DOI":"10.1056\/NEJM199405053301808"},{"key":"10.1124\/jpet.104.072843_bib32","doi-asserted-by":"crossref","unstructured":"Patrono C, Patrignani P, and Garc\u00eda Rodr\u00edguez LA (2001) Cyclooxygenase-selective inhibition of prostanoid formation: transducing biochemical selectivity into clinical read-outs. J Clin Investig 108:7\u2013 13.","DOI":"10.1172\/JCI13418"},{"key":"10.1124\/jpet.104.072843_bib33","doi-asserted-by":"crossref","unstructured":"Paul-Clark MJ, Van Cao T, Moradi-Bidhendi N, Cooper D, and Gilroy DW (2004) 15-Epi-lipoxin A4-mediated induction of nitric oxide explains how aspirin inhibits acute inflammation. J Exp Med 200:69\u2013 78.","DOI":"10.1084\/jem.20040566"},{"key":"10.1124\/jpet.104.072843_bib34","doi-asserted-by":"crossref","unstructured":"Pearson CM, Waksman BH, and Sharp JT (1961) Studies on arthritis and other lesions induced in rats by injection of mycobacterial adjuvant. J Exp Med 113:485\u2013 509.","DOI":"10.1084\/jem.113.3.485"},{"key":"10.1124\/jpet.104.072843_bib35","doi-asserted-by":"crossref","unstructured":"Roth GJ, Stanford N, and Majerus PW (1975) Acetylation of prostaglandin synthase by aspirin. Proc Natl Acad Sci USA 72:3073\u2013 3077.","DOI":"10.1073\/pnas.72.8.3073"},{"key":"10.1124\/jpet.104.072843_bib36","unstructured":"Rahme E, Pilote L, and Lelorier J (2001) Association of conventional non-aspirin nonsteroidal anti-inflammation drugs (NSAIDs) with hospitalizations for myocardial infarction. Arthritis Rheum 44 (Suppl):S230."},{"key":"10.1124\/jpet.104.072843_bib37","doi-asserted-by":"crossref","unstructured":"Serhan CN, Hong S, Gronert K, Colgan SP, Devchand PR, Mirick G, and Moussignac RL (2002) Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J Exp Med 196:1025\u2013 1037.","DOI":"10.1084\/jem.20020760"},{"key":"10.1124\/jpet.104.072843_bib38","doi-asserted-by":"crossref","unstructured":"Serhan CN and Oliw E (2001) Unorthodox routes to prostanoid formation: new twists in cyclooxygenase-initiated pathways. J Clin Investig 107:1481\u2013 1489.","DOI":"10.1172\/JCI13375"},{"key":"10.1124\/jpet.104.072843_bib39","doi-asserted-by":"crossref","unstructured":"Silverstein FE, Faich G, Goldstein JL, Simon LS, Pincus T, Whelton A, Makuch R, Eisen G, Agrawal NM, Stenson WF, et al. (2000) Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study. JAMA (J Am Med Assoc) 284:1247\u2013 1255.","DOI":"10.1001\/jama.284.10.1247"},{"key":"10.1124\/jpet.104.072843_bib40","doi-asserted-by":"crossref","unstructured":"Takano T, Clish CB, Gronert K, Petasis NA, and Serhan CN (1998) Neutrophil-mediated changes in vascular permeability are inhibited by topical application of aspirin-triggered 15-epi-lipoxin A4 and novel lipoxin B4 stable analogues. J Clin Investig 101:819\u2013 826.","DOI":"10.1172\/JCI1578"},{"key":"10.1124\/jpet.104.072843_bib41","doi-asserted-by":"crossref","unstructured":"Takano T, Fiore S, Maddox JF, Brady HR, Petasis NA, and Serhan CN (1997) Aspirin-triggered 15-epi-lipoxin A4 (LXA4) and LXA4 stable analogues are potent inhibitors of acute inflammation: evidence for anti-inflammatory receptors. J Exp Med 185:1693\u2013 1704.","DOI":"10.1084\/jem.185.9.1693"},{"key":"10.1124\/jpet.104.072843_bib42","doi-asserted-by":"crossref","unstructured":"Wallace JL and Cirino G (1994) The development of gastrointestinal-sparing nonsteroidal anti-inflammatory drugs. Trends Pharmacol Sci 15:405\u2013 406.","DOI":"10.1016\/0165-6147(94)90083-3"},{"key":"10.1124\/jpet.104.072843_bib43","doi-asserted-by":"crossref","unstructured":"Wallace JL, McKnight W, Reuter BK, and Vergnolle N (2000) NSAID-induced gastric damage in rats: requirement for inhibition of both cyclooxygenase 1 and 2. Gastroenterology 119:706\u2013 714.","DOI":"10.1053\/gast.2000.16510"},{"key":"10.1124\/jpet.104.072843_bib44","doi-asserted-by":"crossref","unstructured":"Wallace JL, McKnight W, Wilson TL, Del Soldato P, and Cirino G (1997) Reduction of shock-induced gastric damage by a nitric oxide-releasing aspirin derivative: role of neutrophils. Am J Physiol 273:G1246\u2013 G1251.","DOI":"10.1152\/ajpgi.1997.273.6.G1246"},{"key":"10.1124\/jpet.104.072843_bib45","doi-asserted-by":"crossref","unstructured":"Wallace JL, Reuter B, Cicala C, McKnight W, Grisham MB, and Cirino G (1994) Novel nonsteroidal anti-inflammatory drug derivatives with markedly reduced ulcerogenic properties in the rat. Gastroenterology 107:173\u2013 179.","DOI":"10.1016\/0016-5085(94)90074-4"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524317136?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524317136?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.104.072843","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T21:09:32Z","timestamp":1739999372000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524317136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,12]]}},"alternative-id":["S0022356524317136"],"URL":"https:\/\/doi.org\/10.1124\/jpet.104.072843","relation":{},"ISSN":["0022-3565"],"issn-type":[{"type":"print","value":"0022-3565"}],"subject":[],"published":{"date-parts":[[2004,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nitric Oxide (NO)-Releasing Naproxen (HCT-3012 [(S)-6-Methoxy-\u03b1-methyl-2-naphthaleneacetic Acid 4-(Nitrooxy)butyl Ester]) Interactions with Aspirin in Gastric Mucosa of Arthritic Rats Reveal a Role for Aspirin-Triggered Lipoxin, Prostaglandins, and NO in Gastric Protection","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.104.072843","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2004 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}